<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03086265</url>
  </required_header>
  <id_info>
    <org_study_id>36060</org_study_id>
    <nct_id>NCT03086265</nct_id>
  </id_info>
  <brief_title>Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery</brief_title>
  <official_title>The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether laser laryngeal surgery can be safely and
      potentially more effectively performed without the use of tracheal intubation or jet
      ventilation, under completely tubeless conditions. The patient's gas exchange will be
      supported by rapid insufflation of high-flow oxygen through specialized nasal cannula: the so
      called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange (THRIVE).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 24, 2017</start_date>
  <completion_date type="Anticipated">June 14, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of THRIVE for laser laryngeal surgery</measure>
    <time_frame>intraoperative</time_frame>
    <description>safety of high oxygen concentration during laser surgery with absent fuel source, safe duration of surgery as judged by arterial blood gas analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of THRIVE on operating time</measure>
    <time_frame>intraoperative</time_frame>
    <description>duration of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of jet ventilation on carbon dioxide (CO2) elimination during THRIVE</measure>
    <time_frame>intraoperative</time_frame>
    <description>Partial arterial CO2 pressure (PaCO2) measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic safety profile of THRIVE under total intravenous anesthesia with propofol and remifentanil</measure>
    <time_frame>intraoperative</time_frame>
    <description>non-invasive cardiac output monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' analgesic consumption</measure>
    <time_frame>recovery room to 7th postoperative day</time_frame>
    <description>Pain medication consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's recovery room profile</measure>
    <time_frame>1-2 hr after procedure</time_frame>
    <description>time to discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Otorhinolaryngologic Surgical Procedures</condition>
  <condition>Laser Therapy</condition>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high flow nasal oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endotracheal tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tracheal intubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THRIVE</intervention_name>
    <description>active nasal oxygen delivery system</description>
    <arm_group_label>THRIVE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endotracheal tube</intervention_name>
    <description>Plastic tube for supporting ventilation during surgery</description>
    <arm_group_label>Endotracheal tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for laser laryngeal surgery

        Exclusion Criteria:

          1. Patients with significantly decreased myocardial function (ejection fraction &lt; 50%)

          2. Patients with abnormal cardiac rhythm and conduction abnormalities, except for
             patients with isolated, asymptomatic premature atrial and ventricular contractions.

          3. Patients with significant peripheral vascular disease, such as those with the symptoms
             of intermittent claudication.

          4. Patients with known significant cerebrovascular disease, such as history of
             cerebrovascular accidents (CVAs) and transient ischemic attacks (TIAs) .

          5. Patients with significant renal insufficiency, as manifested by estimated glomerular
             filtration rate (eGFR) &lt; 60 ml/min/1.73 m2.

          6. Patients with electrolyte (K+, Ca++) abnormalities, as determined by the lab values
             outside of a normal range.

          7. Patients with the history or symptoms of increased intracranial pressure or reduced
             intracranial compliance (e.g. headaches, nausea and vomiting, visual changes, mental
             changes).

          8. Patients with skull base defects.

          9. Patients with pulmonary hypertension who have pulmonary artery pressures above the
             normal range.

         10. Patients with significant chronic obstructive or restrictive lung diseases, as
             manifested by known history of baseline chronic hypoxia and/or hypercapnia, and/or
             baseline room air oxygen saturation (SpO2) &lt; 95% .

         11. Obese patients with BMI &gt; 35 kg/m2.

         12. Patients with severe and poorly controlled gastroesophageal reflux disease despite
             medical treatment.

         13. Patients with hiatal hernia and full stomach patients.

         14. Patient's refusal to participate in the study.

         15. Patients who do not understand English or mentally handicapped. Pregnant or
             breastfeeding patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darrell M Wilson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vladimir Nekhendzy</last_name>
    <phone>6504984055</phone>
    <email>nek@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford Hospital and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Nekhendzy</last_name>
      <email>nek@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Vladimir Nekhendzy</investigator_full_name>
    <investigator_title>Clinical Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>airway management</keyword>
  <keyword>high flow nasal oxygen high flow nasal cannula THRIVE</keyword>
  <keyword>high flow nasal cannula THRIVE</keyword>
  <keyword>THRIVE</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

